Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEHXK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,169
Award facts
- Contract value 100% obligated
- $83,168.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $83.2K to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9M vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies globally.
RINVOQ ER is an advanced pharmaceutical product used primarily for treating rheumatoid arthritis and other inflammatory conditions. As a child contract under the DLA's existing pharmaceutical prime vendor arrangement, this delivery order represents routine fulfillment of federal medical supply needs with completion scheduled for September 24, 2025. The award demonstrates AmerisourceBergen's continued role as a preferred supplier within the federal healthcare procurement framework, particularly for specialized pharmaceutical commodities supporting Defense Health Agency and other government healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FEHXK?
SPE2DB25FEHXK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FEHXK worth?
The government has obligated $83,169 on SPE2DB25FEHXK.
Is contract SPE2DB25FEHXK an order under another contract?
Yes. SPE2DB25FEHXK is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHXK competed?
The extent of competition for SPE2DB25FEHXK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award